Mostrar el registro sencillo del registro

dc.rights.licenceAtribución-NoComercial 4.0 Internacional*
dc.contributor.authorAschner Montoya, Pablo
dc.contributor.authorAguilar Salinas, Carlos
dc.contributor.authorAguirre, Loreto
dc.contributor.authorFranco, Laercio
dc.contributor.authorGagliardino, Juan José
dc.contributor.authorGorban de Lapertosa, Sylvia
dc.contributor.authorSeclen, Segundo
dc.contributor.authorVinocour, Mary
dc.coverage.spatialAmérica Centralspa
dc.coverage.spatialAmérica del Surspa
dc.date.accessioned2021-02-18T02:37:33Z
dc.date.available2021-02-18T02:37:33Z
dc.date.created2014-02-01
dc.identifierhttps://www.diabetesresearchclinicalpractice.com/article/S0168-8227(13)00393-8/fulltextspa
dc.identifier.issn0168-8227 / 1872-8227 (Electrónico)spa
dc.identifier.urihttp://hdl.handle.net/10554/53010
dc.formatPDFspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.titleDiabetes in south and central america : an updatespa
dc.type.hasversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.description.quartilewosQ1spa
dc.description.quartilescopusQ1spa
dc.identifier.doihttps://doi.org/10.1016/j.diabres.2013.11.010spa
dc.subject.keywordDiabetesspa
dc.subject.keywordSouth and Central Americaspa
dc.subject.keywordGlycemic controlspa
dc.subject.keywordHbA1cspa
dc.subject.keywordPrevalancespa
dc.subject.keywordImpaired Glucose Tolerancespa
dc.description.abstractenglishThe estimated population of the South and Central America (SACA) Region is 467.6 million and 64% is in the age range of 20–79 years but the population pyramid and age distribution are changing. The average prevalence of diabetes in the Region is 8.0% and is expected to reach 9.8% by the year 2035. Prevalence is much lower in rural settings than in urban and the differences attributed to lifestyle changes may be a target for intervention. The indigenous population is a particularly vulnerable group needing special attention. On average, 24% of the adult cases with diabetes are undiagnosed but in some countries this is still as high as 50%. Health expenditure due to diabetes in the Region is around 9% of the global total. Inadequate glycemic control, defined as HbA1c >7%, is a strong predictor of chronic complications which increase resource use in the Region and less than half of the patients enrolled in diabetes care programmes are at target. Fifty percent or more of the adult population is overweight/obese and around one third of the adult population has metabolic syndrome using regional cutoffs for waist circumference. The number of people with IGT is almost equal to those with diabetes presenting an additional challenge for prevention. Children with type 1 diabetes represent only 0.2% of the total population with diabetes but the incidence may be increasing. In many places they have limited access to insulin, and even when available, it is not used appropriately. The available epidemiological data provide the background to act in developing national diabetes programmes which integrate diabetes care with cardiovascular prevention and promote diabetes prevention as well.spa
dc.type.localArtículo de revistaspa
dc.contributor.corporatenamePontificia Universidad Javeriana. Facultad de Medicina. Departamento de Endocrinología
dc.identifier.instnameinstname:Pontificia Universidad Javerianaspa
dc.identifier.reponamereponame:Repositorio Institucional - Pontificia Universidad Javerianaspa
dc.identifier.repourlrepourl:https://repository.javeriana.edu.cospa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.relation.citationstartpage238spa
dc.relation.citationendpage243spa
dc.relation.ispartofjournalDiabetes Research and Clinical Practicespa
dc.relation.citationvolume103spa
dc.relation.citationissue2spa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Ficheros en el registro

Thumbnail

Este registro aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del registro

Atribución-NoComercial 4.0 Internacional
Excepto si se señala otra cosa, la licencia del registro se describe como Atribución-NoComercial 4.0 Internacional